Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06336239
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2023-12-27
Brief Title:
PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China a National Cross-sectional Study
Sponsor:
Beijing Anzhen Hospital
Organization:
Beijing Anzhen Hospital
Study Overview
Official Title:
PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China a National Cross-sectional Study
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PLACARD
Brief Summary:
The association between Cardiovascular Disease CVD and Chronic Kidney Disease CKD is well established Traditional risk factors for CVD and CKD are similar with type 2 diabetes mellitus T2DM being the most prevalent risk factor However CKD is underdiagnosed and undertreated in patients with CVD Further understanding of the combination of CKD in CVD patients is important to formulate prevention and treatment strategies for CVD patients and high-risk groups reduce adverse events in CVD patients and prevent progression of CKD to End Stage Renal Disease ESRD
Detailed Description:
The PLACARD study will include approximately 3000 patients presenting to the cardiology department with type 2 diabetes and cardiovascular disease The aim of this study was to assess the prevalence of proteinuria urinary ACR in type 2 diabetic patients with different cardiovascular diseases both inpatient and outpatient in the cardiology departments of secondary and tertiary hospitals in China Participants will be recruited at 30 clinical centers for a period of six months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None